Rui-Peng Jia

604 total citations
29 papers, 504 citations indexed

About

Rui-Peng Jia is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rui-Peng Jia has authored 29 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rui-Peng Jia's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Rui-Peng Jia is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Rui-Peng Jia collaborates with scholars based in China. Rui-Peng Jia's co-authors include Yu‐Zheng Ge, Luwei Xu, Ruiyang Wu, Yang Li, Jiageng Zhu, Wencheng Li, Liuhua Zhou, Zheng Xu, Zheng Xu and Luwei Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Gene.

In The Last Decade

Rui-Peng Jia

27 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui-Peng Jia China 15 316 248 85 64 62 29 504
Ziba Nariman‐Saleh‐Fam Iran 17 419 1.3× 309 1.2× 29 0.3× 48 0.8× 67 1.1× 39 610
Ana Katušić Bojanac Croatia 12 307 1.0× 105 0.4× 65 0.8× 109 1.7× 26 0.4× 54 470
Wen Yuan China 12 232 0.7× 155 0.6× 50 0.6× 25 0.4× 46 0.7× 28 368
Wei Cang China 9 213 0.7× 159 0.6× 90 1.1× 60 0.9× 79 1.3× 19 470
Xiangyang Zeng China 8 225 0.7× 174 0.7× 135 1.6× 60 0.9× 101 1.6× 17 492
Sung Sun Kim South Korea 11 244 0.8× 101 0.4× 168 2.0× 80 1.3× 33 0.5× 57 520
Tiefeng Cao China 12 262 0.8× 175 0.7× 45 0.5× 47 0.7× 43 0.7× 24 564
Anna Wójcicka Poland 15 481 1.5× 398 1.6× 46 0.5× 36 0.6× 45 0.7× 28 749
Hongsheng Yang China 14 226 0.7× 113 0.5× 87 1.0× 113 1.8× 71 1.1× 32 503
Yanlong Yang China 14 188 0.6× 123 0.5× 133 1.6× 99 1.5× 35 0.6× 27 441

Countries citing papers authored by Rui-Peng Jia

Since Specialization
Citations

This map shows the geographic impact of Rui-Peng Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui-Peng Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui-Peng Jia more than expected).

Fields of papers citing papers by Rui-Peng Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui-Peng Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui-Peng Jia. The network helps show where Rui-Peng Jia may publish in the future.

Co-authorship network of co-authors of Rui-Peng Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Rui-Peng Jia. A scholar is included among the top collaborators of Rui-Peng Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui-Peng Jia. Rui-Peng Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Rui-Peng, et al.. (2025). Integrative Application of Traditional Chinese Medicine in Interventional Oncology: A Comprehensive Review. Bratislavské lekárske listy/Bratislava medical journal. 126(8). 1647–1654.
2.
Li, Yang, Luwei Xu, Ning Liu, et al.. (2022). Tumor Cell-Derived Exosomal circ-PRKCI Promotes Proliferation of Renal Cell Carcinoma via Regulating miR-545-3p/CCND1 Axis. Cancers. 15(1). 123–123. 16 indexed citations
3.
Yang, Li, et al.. (2020). The Potential Roles of RNA N6-Methyladenosine in Urological Tumors. Frontiers in Cell and Developmental Biology. 8. 579919–579919. 23 indexed citations
4.
Li, Yang, Yu‐Zheng Ge, Luwei Xu, & Rui-Peng Jia. (2019). Circular RNA ITCH: A novel tumor suppressor in multiple cancers. Life Sciences. 254. 117176–117176. 71 indexed citations
5.
Ge, Yu‐Zheng, Tao Xu, Weijun Cao, et al.. (2017). A Molecular Signature of Two Long Non-Coding RNAs in Peripheral Blood Predicts Acute Renal Allograft Rejection. Cellular Physiology and Biochemistry. 44(3). 1213–1223. 19 indexed citations
6.
Ge, Yu‐Zheng, Luwei Xu, Changcheng Zhou, et al.. (2017). A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1. Journal of Cancer. 8(13). 2643–2652. 20 indexed citations
7.
Zhou, Changcheng, Yu‐Zheng Ge, Ruiyang Wu, et al.. (2017). Limited Clinical Utility of Remote Ischemic Conditioning in Renal Transplantation: A Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 12(1). e0170729–e0170729. 10 indexed citations
8.
Ge, Yu‐Zheng, Luwei Xu, Zheng Xu, et al.. (2015). Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma. Medicine. 94(16). e767–e767. 22 indexed citations
9.
Xu, Zheng, Yu‐Zheng Ge, Jiageng Zhu, et al.. (2015). MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival. Tumor Biology. 36(10). 8159–8166. 26 indexed citations
10.
Ge, Yu‐Zheng, Ruiyang Wu, Hui Xin, et al.. (2015). A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 141(7). 1291–1299. 39 indexed citations
11.
Ge, Yu‐Zheng, Yu Peng, Rui-Peng Jia, et al.. (2014). Association between transforming growth factor beta-1 +869T/C polymorphism and acute rejection of solid organ allograft: A meta-analysis and systematic review. Transplant Immunology. 30(2-3). 76–83. 8 indexed citations
12.
Ge, Yu‐Zheng, Zheng Xu, Luwei Xu, et al.. (2014). Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene. 551(1). 86–91. 13 indexed citations
13.
Ge, Yu‐Zheng, Luwei Xu, Rui-Peng Jia, et al.. (2014). Association of polymorphisms in estrogen receptors (ESR1 and ESR2) with male infertility: a meta-analysis and systematic review. Journal of Assisted Reproduction and Genetics. 31(5). 601–611. 26 indexed citations
14.
Ge, Yu‐Zheng, Qian Ge, Minghao Li, et al.. (2014). Association between human leukocyte antigen-G 14-bp insertion/deletion polymorphism and cancer risk: A meta-analysis and systematic review. Human Immunology. 75(8). 827–832. 28 indexed citations
15.
Ge, Yu‐Zheng, Ruiyang Wu, Rui-Peng Jia, et al.. (2014). Combined Effects of TGFB1 +869 T/C and +915 G/C Polymorphisms on Acute Rejection Risk in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis. PLoS ONE. 9(4). e93938–e93938. 12 indexed citations
16.
Ge, Yu‐Zheng, Yidan Wang, Zheng Xu, et al.. (2014). Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis. Tumor Biology. 35(7). 6405–6414. 7 indexed citations
17.
Zhao, Yan, et al.. (2014). Prostate stem cell antigen rs2294008 (C>T) polymorphism and bladder cancer risk: a meta-analysis based on cases and controls. Genetics and Molecular Research. 13(3). 5534–5540. 8 indexed citations
18.
Ge, Yu‐Zheng, Luwei Xu, Rui-Peng Jia, et al.. (2013). The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Tumor Biology. 35(4). 3881–3890. 22 indexed citations
19.
Wu, Jianping, Jun Liu, Rui-Peng Jia, & Hongbin Song. (2013). Nur77 Inhibits Androgen-Induced Bladder Cancer Growth. Cancer Investigation. 31(10). 654–660. 20 indexed citations
20.
Ge, Yu‐Zheng, Ruiyang Wu, Rui-Peng Jia, et al.. (2013). Association between interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies. Molecular Biology Reports. 40(10). 6043–6051. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziba Nariman‐Saleh‐Fam Breakdown of academic impact, for papers by Ana Katušić Bojanac Breakdown of academic impact, for papers by Wen Yuan Breakdown of academic impact, for papers by Wei Cang Breakdown of academic impact, for papers by Xiangyang Zeng Breakdown of academic impact, for papers by Sung Sun Kim Breakdown of academic impact, for papers by Tiefeng Cao Breakdown of academic impact, for papers by Anna Wójcicka Breakdown of academic impact, for papers by Hongsheng Yang Breakdown of academic impact, for papers by Yanlong Yang
Rankless by CCL
2026